Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Fill-finish Pharmaceutical Contract Manufacturing Market
Fill-finish Pharmaceutical Contract Manufacturing Market Trends
- Report ID: GMI9281
- Published Date: Apr 2024
- Report Format: PDF
Fill-finish Pharmaceutical Contract Manufacturing Market Trends
- Pharmaceutical companies are increasingly turning to contract manufacturers to streamline their operations, reduce costs, and enhance flexibility in response to changing market demands.
- Outsourcing fill-finish services allows companies to focus on their core competencies such as research and development, while leveraging the specialized expertise and infrastructure of contract manufacturers for the final stages of production.
- This trend is particularly pronounced in the biopharmaceutical sector, where the complexity of manufacturing processes and the need for specialized facilities have made outsourcing an attractive option.
- As a result, the fill-finish pharmaceutical contract manufacturing industry is expected to experience robust growth in the coming years, driven by the increasing adoption of outsourcing strategies by pharmaceutical companies.
Frequently Asked Questions (FAQ) :
The market size for fill-finish pharmaceutical contract manufacturing was valued at USD 7.7 billion in 2023 and is anticipated to grow at 6.2% CAGR between 2024 – 2032, driven by the increasing demand for biopharmaceuticals and parenteral drugs requiring specialized filling and finishing processes.
The vials segment in the fill-finish pharmaceutical contract manufacturing market accounted for USD 4.1 billion in 2023, due to their durability, sterility, and ease of use.
North America fill-finish pharmaceutical contract manufacturing market is anticipated to grow at 5.9% CAGR from 2024 to 2032, attributed to the advanced healthcare infrastructure and a strong regulatory framework.
Boehringer Ingelheim International GmbH, Catalent Inc, Eurofins Scientific, Fresenius Kabi Contract Manufacturing, MabPlex International Co. Ltd., Novartis AG, Recipharm AB, Societal CDMO, Simtra BioPharma Solutions (Baxter International Inc.) and Symbiosis Pharmaceutical Services
Fill-finish Pharmaceutical Contract Manufacturing Market Scope
×
Get a free sample of
Fill-finish Pharmaceutical Contract Manufacturing Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below